(NASDAQ: AXGN) Axogen's forecast annual revenue growth rate of 10.64% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.8%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 24.86%.
Axogen's revenue in 2025 is $214,709,000.On average, 11 Wall Street analysts forecast AXGN's revenue for 2025 to be $10,336,466,188, with the lowest AXGN revenue forecast at $9,898,765,665, and the highest AXGN revenue forecast at $10,678,693,572. On average, 11 Wall Street analysts forecast AXGN's revenue for 2026 to be $11,972,885,002, with the lowest AXGN revenue forecast at $11,286,585,341, and the highest AXGN revenue forecast at $12,581,699,216.
In 2027, AXGN is forecast to generate $13,348,712,882 in revenue, with the lowest revenue forecast at $10,151,977,032 and the highest revenue forecast at $14,606,006,481.